Surge in Counterfeit Injectables Prompts Safety Warning from AAFPRS
The AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
The AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
An investigation into cosmetic surgery chains has prompted consumer warnings from industry groups representing plastic surgeons and a call for more transparency around physician disciplinary actions in California.